Johnson & Johnson JNJ

$282.12 +5.90 (2.14%)

Valuation

Market cap
664,947,200,000
Revenue TTM
$94,193,000,000
Net income TTM
$26,804,000,000
P/E (trailing)
25.57
P/E (forward)
24.50
Profit margin
28.46%
Debt to equity
0.44

Trading

Volume
4,342,795
Avg volume
7,213,330
Day's range
$276.20 – $282.73
Shares out
2,407,310,000
Stochastic %K
67%
Beta
0.22
Analysts
Moderate Buy
Price target
$281.64

Price

Company profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular...

Show more

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Industry
Drug Manufacturers - General
Sector
Healthcare
Phone
732 524 0400
Website
https://www.jnj.com
Address
One Johnson & Johnson Plaza, New Brunswick, United States

Latest news

Stocktwits

TroyTiger Nov 9, 8:52 PM
$TGTX buyout offers will ne coming on I think, buying any little dips. 260mil revenue this Qtr, X4 = 1.040 Billion. BUT with our current growth rate, next 4 quarters makes it over 1.1Bil. $JNJ, $MRK, $LLY, $SNY taking notice.
1 replies
HydrogenH2 Nov 9, 8:37 PM
$JNJ When you get your yearly dividend in a few hours trade ... Don't be too greedy and take it... !!
0 replies
frb1985 Nov 9, 7:40 PM
$JNJ Another new all time high. 💪 Miss Outcomes and Suite510 😆
0 replies
HydrogenH2 Nov 9, 7:26 PM
$JNJ But don't be too greedy from past graph...lol
0 replies
GettnFibbywIT Nov 9, 7:17 PM
$JNJ $XLV $IHE $SPY 👏👏
0 replies
Stocktwits52wHighs Nov 9, 6:46 PM
$JNJ printed a new 52-week high today
0 replies
HydrogenH2 Nov 9, 4:58 PM
$JNJ Took 75% profits... Bought some $VZ with it !! 🤪
1 replies
focafoca99 Nov 9, 4:45 PM
$JNJ released FDA accelerated approval for RYBREVANT FASPRO for head and neck cancer. https://www.rapidticker.com/news/jnj-raised-outlooks-and-a-cancer-48c912
0 replies